$TELA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in TELA Bio, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in TELA Bio, Inc.. Get notifications about new insider transactions in TELA Bio, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 09 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 12.99 | 10,000 | 129,900 | 1,704,262 | 1.7 M to 1.7 M (+0.59 %) | |
May 20 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 13.30 | 8,525 | 113,383 | 1,691,234 | 1.7 M to 1.7 M (+0.51 %) | |
May 20 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 13.44 | 450 | 6,048 | 1,682,709 | 1.7 M to 1.7 M (+0.03 %) | |
May 20 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 13.30 | 3,546 | 47,162 | 1,682,259 | 1.7 M to 1.7 M (+0.21 %) | |
May 14 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 11.87 | 10,000 | 118,700 | 1,665,555 | 1.7 M to 1.7 M (+0.60 %) | |
May 14 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 12.49 | 5,000 | 62,450 | 1,655,555 | 1.7 M to 1.7 M (+0.30 %) | |
May 13 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 12.75 | 7,500 | 95,625 | 1,650,555 | 1.6 M to 1.7 M (+0.46 %) | |
May 13 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 12.75 | 7,500 | 95,625 | 1,650,555 | 1.6 M to 1.7 M (+0.46 %) | |
May 13 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 12.93 | 7,500 | 96,975 | 1,643,055 | 1.6 M to 1.6 M (+0.46 %) | |
May 13 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 12.93 | 7,500 | 96,975 | 1,643,055 | 1.6 M to 1.6 M (+0.46 %) | |
May 13 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 13.15 | 7,500 | 98,625 | 1,635,555 | 1.6 M to 1.6 M (+0.46 %) | |
May 13 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 13.15 | 7,500 | 98,625 | 1,635,555 | 1.6 M to 1.6 M (+0.46 %) | |
May 13 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 13.15 | 6,499 | 85,462 | 1,628,055 | 1.6 M to 1.6 M (+0.40 %) | |
May 13 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 13.15 | 6,499 | 85,462 | 1,628,055 | 1.6 M to 1.6 M (+0.40 %) | |
May 13 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 13.28 | 7,500 | 99,600 | 1,621,556 | 1.6 M to 1.6 M (+0.46 %) | |
May 13 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 13.28 | 7,500 | 99,600 | 1,621,556 | 1.6 M to 1.6 M (+0.46 %) | |
May 13 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 13.41 | 200 | 2,682 | 1,614,056 | 1.6 M to 1.6 M (+0.01 %) | |
May 13 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 13.41 | 200 | 2,682 | 1,614,056 | 1.6 M to 1.6 M (+0.01 %) | |
May 13 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 13.49 | 15,000 | 202,350 | 1,613,856 | 1.6 M to 1.6 M (+0.94 %) | |
May 13 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 13.49 | 15,000 | 202,350 | 1,613,856 | 1.6 M to 1.6 M (+0.94 %) | |
May 13 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 13.51 | 5,000 | 67,550 | 1,598,856 | 1.6 M to 1.6 M (+0.31 %) | |
May 13 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 13.51 | 5,000 | 67,550 | 1,598,856 | 1.6 M to 1.6 M (+0.31 %) | |
May 13 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 13.54 | 5,000 | 67,700 | 1,593,856 | 1.6 M to 1.6 M (+0.31 %) | |
May 13 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 13.54 | 5,000 | 67,700 | 1,593,856 | 1.6 M to 1.6 M (+0.31 %) | |
May 13 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 13.59 | 365 | 4,960 | 1,588,856 | 1.6 M to 1.6 M (+0.02 %) | |
May 13 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 13.59 | 365 | 4,960 | 1,588,856 | 1.6 M to 1.6 M (+0.02 %) | |
May 13 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 13.54 | 4,678 | 63,340 | 1,588,491 | 1.6 M to 1.6 M (+0.30 %) | |
May 13 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 13.54 | 4,678 | 63,340 | 1,588,491 | 1.6 M to 1.6 M (+0.30 %) | |
May 13 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 13.61 | 625 | 8,506 | 1,583,813 | 1.6 M to 1.6 M (+0.04 %) | |
May 13 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 13.61 | 625 | 8,506 | 1,583,813 | 1.6 M to 1.6 M (+0.04 %) | |
May 13 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 13.57 | 2,893 | 39,258 | 1,583,188 | 1.6 M to 1.6 M (+0.18 %) | |
May 13 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 13.57 | 2,893 | 39,258 | 1,583,188 | 1.6 M to 1.6 M (+0.18 %) | |
May 13 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 13.67 | 206 | 2,816 | 1,580,295 | 1.6 M to 1.6 M (+0.01 %) | |
May 13 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 13.67 | 206 | 2,816 | 1,580,295 | 1.6 M to 1.6 M (+0.01 %) | |
May 13 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 12.88 | 37,851 | 487,521 | 1,580,089 | 1.5 M to 1.6 M (+2.45 %) | |
May 13 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 12.88 | 37,851 | 487,521 | 1,580,089 | 1.5 M to 1.6 M (+2.45 %) | |
May 13 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 13.11 | 5,000 | 65,550 | 1,542,238 | 1.5 M to 1.5 M (+0.33 %) | |
May 13 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 13.11 | 5,000 | 65,550 | 1,542,238 | 1.5 M to 1.5 M (+0.33 %) | |
May 13 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 13.94 | 2,660 | 37,080 | 1,537,238 | 1.5 M to 1.5 M (+0.17 %) | |
May 13 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 13.94 | 2,660 | 37,080 | 1,537,238 | 1.5 M to 1.5 M (+0.17 %) | |
May 13 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 13.79 | 10,000 | 137,900 | 1,534,578 | 1.5 M to 1.5 M (+0.66 %) | |
May 13 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 13.79 | 10,000 | 137,900 | 1,534,578 | 1.5 M to 1.5 M (+0.66 %) | |
Apr 02 2021 | TELA | TELA Bio, Inc. | KOBLISH ANTONY | Chief Executive Off ... | Grant | A | 0.00 | 5,439 | 0 | 194,424 | 189 K to 194.4 K (+2.88 %) |
Apr 02 2021 | TELA | TELA Bio, Inc. | Greenhalgh Ellis Skott | Chief Technology Of ... | Grant | A | 0.00 | 2,789 | 0 | 24,899 | 22.1 K to 24.9 K (+12.61 %) |
Apr 02 2021 | TELA | TELA Bio, Inc. | Murphy Peter C. | Chief Commercial Of ... | Grant | A | 0.00 | 2,298 | 0 | 13,498 | 11.2 K to 13.5 K (+20.52 %) |
Apr 02 2021 | TELA | TELA Bio, Inc. | Brennan Nora | Chief Financial Off ... | Grant | A | 0.00 | 2,928 | 0 | 17,696 | 14.8 K to 17.7 K (+19.83 %) |
Feb 26 2021 | TELA | TELA Bio, Inc. | KOBLISH ANTONY | Chief Executive Off ... | Option Exercise | A | 16.99 | 63,600 | 1,080,564 | 63,600 | |
Feb 26 2021 | TELA | TELA Bio, Inc. | KOBLISH ANTONY | Chief Executive Off ... | Grant | A | 0.00 | 34,900 | 0 | 188,985 | 154.1 K to 189 K (+22.65 %) |
Feb 23 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 14.29 | 2,822 | 40,326 | 1,524,578 | 1.5 M to 1.5 M (+0.19 %) | |
Feb 23 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 14.08 | 250 | 3,520 | 1,521,756 | 1.5 M to 1.5 M (+0.02 %) | |
Feb 23 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 14.16 | 1,119 | 15,845 | 1,521,506 | 1.5 M to 1.5 M (+0.07 %) | |
Feb 23 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 13.93 | 7,760 | 108,097 | 1,520,387 | 1.5 M to 1.5 M (+0.51 %) | |
Feb 23 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 13.68 | 13,950 | 190,836 | 1,512,627 | 1.5 M to 1.5 M (+0.93 %) | |
Feb 23 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 14.03 | 5,000 | 70,150 | 1,498,677 | 1.5 M to 1.5 M (+0.33 %) | |
Feb 23 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 14.24 | 1,544 | 21,987 | 1,493,677 | 1.5 M to 1.5 M (+0.10 %) | |
Feb 23 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 13.88 | 763 | 10,590 | 1,492,133 | 1.5 M to 1.5 M (+0.05 %) | |
Feb 23 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 13.96 | 9,075 | 126,687 | 1,491,370 | 1.5 M to 1.5 M (+0.61 %) | |
Feb 23 2021 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, ... | Buy | P | 13.90 | 7,002 | 97,328 | 1,482,295 | 1.5 M to 1.5 M (+0.47 %) | |
Jun 08 2020 | TELA | TELA Bio, Inc. | COLLERAN LISA N | Director | Option Exercise | A | 17.00 | 8,806 | 149,702 | 8,806 | |
Jun 08 2020 | TELA | TELA Bio, Inc. | O'Brien Federica F. | Director | Option Exercise | A | 17.00 | 8,806 | 149,702 | 8,806 | |
Jun 08 2020 | TELA | TELA Bio, Inc. | Oliva Adele C | Director | Option Exercise | A | 17.00 | 8,806 | 149,702 | 8,806 | |
Jun 08 2020 | TELA | TELA Bio, Inc. | Azarbarzin Kurt | Director | Option Exercise | A | 17.00 | 8,806 | 149,702 | 8,806 | |
Jun 08 2020 | TELA | TELA Bio, Inc. | Burgess Vincent J | Director | Option Exercise | A | 17.00 | 8,806 | 149,702 | 8,806 | |
Jun 08 2020 | TELA | TELA Bio, Inc. | EVANS DOUGLAS G | Director | Option Exercise | A | 17.00 | 8,806 | 149,702 | 8,806 | |
Apr 22 2020 | TELA | TELA Bio, Inc. | EVANS DOUGLAS G | Director | Option Exercise | A | 8.42 | 8,000 | 67,360 | 8,000 | |
Apr 22 2020 | TELA | TELA Bio, Inc. | COLLERAN LISA N | Director | Option Exercise | A | 8.42 | 8,000 | 67,360 | 8,000 | |
Apr 22 2020 | TELA | TELA Bio, Inc. | EVANS DOUGLAS G | Director | Option Exercise | A | 8.42 | 8,000 | 67,360 | 8,000 | |
Apr 22 2020 | TELA | TELA Bio, Inc. | COLLERAN LISA N | Director | Option Exercise | A | 8.42 | 8,000 | 67,360 | 8,000 | |
Jan 29 2020 | TELA | TELA Bio, Inc. | Murphy Peter C. | Chief Commercial Of ... | Option Exercise | A | 15.50 | 60,000 | 930,000 | 60,000 | |
Dec 18 2019 | TELA | TELA Bio, Inc. | RTW INVESTMENTS, LP | 10% Owner | Sell | S | 11.32 | 36,000 | 407,617 | 1,139,358 | 1.2 M to 1.1 M (-3.06 %) |
Dec 17 2019 | TELA | TELA Bio, Inc. | RTW INVESTMENTS, LP | 10% Owner | Buy | P | 11.60 | 23,900 | 277,121 | 1,175,358 | 1.2 M to 1.2 M (+2.08 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 28.65 | 758,623 | 21,734,549 | 758,623 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 28.65 | 758,623 | 21,734,549 | 758,623 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 1.16 | 758,623 | 880,003 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 1.16 | 758,623 | 880,003 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 24,142,419 | 0 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 24,142,419 | 0 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 11,878,249 | 0 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 11,878,249 | 0 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 977,820 | 0 | 3,027,542 | 2 M to 3 M (+47.71 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 977,820 | 0 | 3,027,542 | 2 M to 3 M (+47.71 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 481,095 | 0 | 2,049,722 | 1.6 M to 2 M (+30.67 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 481,095 | 0 | 2,049,722 | 1.6 M to 2 M (+30.67 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 13.00 | 384,615 | 4,999,995 | 1,568,627 | 1.2 M to 1.6 M (+32.48 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 13.00 | 384,615 | 4,999,995 | 1,568,627 | 1.2 M to 1.6 M (+32.48 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | KOBLISH ANTONY | Chief Executive Off ... | Option Exercise | C | 28.65 | 10,775 | 308,704 | 10,775 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | KOBLISH ANTONY | Chief Executive Off ... | Option Exercise | C | 1.16 | 10,775 | 12,499 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | KOBLISH ANTONY | Chief Executive Off ... | Option Exercise | C | 0.00 | 351,271 | 0 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | KOBLISH ANTONY | Chief Executive Off ... | Option Exercise | C | 0.00 | 179,685 | 0 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | KOBLISH ANTONY | Chief Executive Off ... | Buy | C | 0.00 | 14,225 | 0 | 154,085 | 139.9 K to 154.1 K (+10.17 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | KOBLISH ANTONY | Chief Executive Off ... | Buy | C | 0.00 | 7,277 | 0 | 139,860 | 132.6 K to 139.9 K (+5.49 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | KOBLISH ANTONY | Chief Executive Off ... | Option Exercise | C | 28.65 | 10,775 | 308,704 | 10,775 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | Ellis Ronald J. Jr. | Director | Option Exercise | C | 0.00 | 14,329,052 | 0 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | KOBLISH ANTONY | Chief Executive Off ... | Option Exercise | C | 1.16 | 10,775 | 12,499 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | Ellis Ronald J. Jr. | Director | Buy | C | 0.00 | 580,357 | 0 | 774,056 | 193.7 K to 774.1 K (+299.62 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | KOBLISH ANTONY | Chief Executive Off ... | Option Exercise | C | 0.00 | 351,271 | 0 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | KOBLISH ANTONY | Chief Executive Off ... | Option Exercise | C | 0.00 | 179,685 | 0 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | KOBLISH ANTONY | Chief Executive Off ... | Buy | C | 0.00 | 14,225 | 0 | 154,085 | 139.9 K to 154.1 K (+10.17 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | KOBLISH ANTONY | Chief Executive Off ... | Buy | C | 0.00 | 7,277 | 0 | 139,860 | 132.6 K to 139.9 K (+5.49 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | Ellis Ronald J. Jr. | Director | Option Exercise | C | 0.00 | 14,329,052 | 0 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | Ellis Ronald J. Jr. | Director | Buy | C | 0.00 | 580,357 | 0 | 774,056 | 193.7 K to 774.1 K (+299.62 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | Quaker BioVentures II LP | 10% Owner | Option Exercise | C | 28.65 | 446,813 | 12,801,192 | 446,813 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | Quaker BioVentures II LP | 10% Owner | Option Exercise | C | 1.16 | 446,813 | 518,303 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | Quaker BioVentures II LP | 10% Owner | Option Exercise | C | 0.00 | 12,763,434 | 0 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | Quaker BioVentures II LP | 10% Owner | Option Exercise | C | 0.00 | 8,530,145 | 0 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | Quaker BioVentures II LP | 10% Owner | Buy | C | 0.00 | 516,947 | 0 | 1,751,100 | 1.2 M to 1.8 M (+41.89 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | Quaker BioVentures II LP | 10% Owner | Buy | C | 0.00 | 345,489 | 0 | 1,234,153 | 888.7 K to 1.2 M (+38.88 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | Quaker BioVentures II LP | 10% Owner | Buy | P | 13.00 | 153,846 | 1,999,998 | 888,664 | 734.8 K to 888.7 K (+20.94 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | Quaker BioVentures II LP | 10% Owner | Option Exercise | C | 28.65 | 446,813 | 12,801,192 | 446,813 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | Quaker BioVentures II LP | 10% Owner | Option Exercise | C | 1.16 | 446,813 | 518,303 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | Quaker BioVentures II LP | 10% Owner | Option Exercise | C | 0.00 | 12,763,434 | 0 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | Quaker BioVentures II LP | 10% Owner | Option Exercise | C | 0.00 | 8,530,145 | 0 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | Quaker BioVentures II LP | 10% Owner | Buy | C | 0.00 | 516,947 | 0 | 1,751,100 | 1.2 M to 1.8 M (+41.89 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | Quaker BioVentures II LP | 10% Owner | Buy | C | 0.00 | 345,489 | 0 | 1,234,153 | 888.7 K to 1.2 M (+38.88 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | Quaker BioVentures II LP | 10% Owner | Buy | P | 13.00 | 153,846 | 1,999,998 | 888,664 | 734.8 K to 888.7 K (+20.94 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Option Exercise | C | 28.65 | 1,665 | 47,702 | 1,665 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Option Exercise | C | 1.16 | 1,665 | 1,931 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Option Exercise | C | 28.65 | 123,653 | 3,542,658 | 123,653 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Option Exercise | C | 1.16 | 123,653 | 143,437 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Option Exercise | C | 0.00 | 72,417 | 0 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Option Exercise | C | 0.00 | 5,377,928 | 0 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Option Exercise | C | 0.00 | 6,643 | 0 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Option Exercise | C | 0.00 | 493,357 | 0 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Buy | C | 0.00 | 217,816 | 0 | 498,606 | 280.8 K to 498.6 K (+77.57 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Option Exercise | C | 28.65 | 1,665 | 47,702 | 1,665 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Buy | C | 0.00 | 19,982 | 0 | 280,790 | 260.8 K to 280.8 K (+7.66 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Option Exercise | C | 1.16 | 1,665 | 1,931 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Buy | C | 0.00 | 2,931 | 0 | 15,875 | 12.9 K to 15.9 K (+22.64 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Option Exercise | C | 28.65 | 123,653 | 3,542,658 | 123,653 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Buy | C | 0.00 | 269 | 0 | 12,944 | 12.7 K to 12.9 K (+2.12 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Option Exercise | C | 1.16 | 123,653 | 143,437 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Buy | P | 13.00 | 75,901 | 986,713 | 260,808 | 184.9 K to 260.8 K (+41.05 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Option Exercise | C | 0.00 | 72,417 | 0 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Buy | P | 13.00 | 10,220 | 132,860 | 12,675 | 2.5 K to 12.7 K (+416.29 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Option Exercise | C | 0.00 | 5,377,928 | 0 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Option Exercise | C | 0.00 | 6,643 | 0 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Option Exercise | C | 0.00 | 493,357 | 0 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Buy | C | 0.00 | 217,816 | 0 | 498,606 | 280.8 K to 498.6 K (+77.57 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Buy | C | 0.00 | 19,982 | 0 | 280,790 | 260.8 K to 280.8 K (+7.66 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | Brennan Nora | Chief Financial Off ... | Option Exercise | C | 0.00 | 86,200 | 0 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Buy | C | 0.00 | 2,931 | 0 | 15,875 | 12.9 K to 15.9 K (+22.64 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | Brennan Nora | Chief Financial Off ... | Buy | C | 0.00 | 3,491 | 0 | 3,668 | 177 to 3.7 K (+1,972.32 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Buy | C | 0.00 | 269 | 0 | 12,944 | 12.7 K to 12.9 K (+2.12 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | Azarbarzin Kurt | Director | Option Exercise | C | 28.65 | 1,665 | 47,702 | 1,665 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Buy | P | 13.00 | 75,901 | 986,713 | 260,808 | 184.9 K to 260.8 K (+41.05 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | Azarbarzin Kurt | Director | Option Exercise | C | 1.16 | 1,665 | 1,931 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Buy | P | 13.00 | 10,220 | 132,860 | 12,675 | 2.5 K to 12.7 K (+416.29 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | Azarbarzin Kurt | Director | Option Exercise | C | 28.65 | 123,653 | 3,542,658 | 123,653 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | Azarbarzin Kurt | Director | Option Exercise | C | 1.16 | 123,653 | 143,437 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | Azarbarzin Kurt | Director | Option Exercise | C | 0.00 | 72,417 | 0 | 0 |